⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27394 | 0.97 | — | — | |
| SCHEMBL265217 | 0.97 | — | — | |
| SCHEMBL264824 | 0.97 | — | — | |
| SCHEMBL1124238 | 0.97 | GABRP (0.59) | — | |
| SCHEMBL311419 | 0.94 | — | — | |
| SCHEMBL11690150 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL8829491 | 0.94 | — | — | |
| Methylamine SCHEMBL6691699 | 0.92 | GABRP (0.61) | — | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL7932482 | 0.87 | GABRP (0.50) | — | |
| Levulinic Acid SCHEMBL165683 | 0.85 | LMNA (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3806906-A1 | NOVEL KETOGENIC COMPOUNDS, COMPOSITIONS, METHODS AND USE THEREOF | Ketofibe (9211-3133 Quebec Inc.) (CA) | 2021-04-21 | — | — | EP | disclosed |
| WO-2019237185-A1 | NOVEL KETOGENIC COMPOUNDS, COMPOSITIONS, METHODS AND USE THEREOF | KETOFIBE (9211-3133 QUEBEC INC.) (CA) | 2019-12-19 | — | — | WO | disclosed |
| EP-2986163-A1 | NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN | Abbott Laboratories (US) | 2016-02-24 | — | — | EP | disclosed |
| US-20160037815-A1 | NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN | ABBOTT LABORATORIES (US) | 2016-02-11 | — | — | US | disclosed |
| WO-2014144048-A1 | NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN | ABBOTT LABORATORIES (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-2512236-A1 | IMPROVED METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) | Metabolic Technologies, Inc. (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011075741-A1 | IMPROVED METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) | METABOLIC TECHNOLOGIES, INC. (US) | 2011-06-23 | — | — | WO | disclosed |
| EP-1750527-A1 | COMPOSITIONS AND METHOD FOR ENHANCING THE BIOAVAILABILITY OF CALCIUM AND MAGNESIUM IN DIETARY SUPPLEMENTS AND FOOD ADDITIVES | Wiley Organics, Inc. (US) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005096846-A1 | COMPOSITION AND METHOD FOR ENHANCING THE BIOAVAILABILITY OF CALCIUM AND MAGNESIUM IN DIETARY SUPPLEMENTS AND FOOD ADDITIVES | WILEY ORGANICS, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| US-20040220266-A1 | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives | WILEY ORGANICS, INC. | 2004-11-04 | — | — | US | disclosed |
| US-20040048925-A1 | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives | WILEY ORGANICS, INC. | 2004-03-11 | — | — | US | disclosed |